17:08 EST Recursion Pharmaceuticals (RXRX) files automatic mixed securities shelf
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on RXRX:
- Recursion Pharmaceuticals’ (RXRX) AI Approach to Drug Discovery Shows Progress
- Cautious Optimism for Recursion Pharmaceuticals Amid Promising REC-994 Data and Awaited Pipeline Updates
- Promising Phase II Results for Recursion Pharmaceuticals’ REC-994 Bolster Buy Rating
- Recursion Pharmaceuticals call volume above normal and directionally bullish
- Short Report: Bears bite into satellite stocks AST SpaceMobile, Telesat